Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of June 27, 2025 is 277.13.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 25.2% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 8.6% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 300.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 286.8105 254.9490 324.4920 254.2700 277.1300 8.13%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $150.079B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $217.309B 16.22
Gilead Sciences (GILD) United States $133.872B 13.90
Vertex Pharmaceuticals (VRTX) United States $113.864B 0.00
Bristol Myers Squibb (BMY) United States $94.937B 6.36
GSK (GSK) United Kingdom $78.925B 9.45
CSL (CSLLY) Australia $76.903B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.250B 13.65
Alnylam Pharmaceuticals (ALNY) United States $41.496B 0.00
Argenex SE (ARGX) Netherlands $34.196B 93.34
BioNTech SE (BNTX) Germany $25.515B 0.00
Royalty Pharma (RPRX) United States $19.830B 8.38
Insmed (INSM) United States $19.301B 0.00
Biogen (BIIB) United States $18.597B 8.02
Illumina (ILMN) United States $14.906B 28.28
Genmab (GNMSF) Denmark $13.948B 14.26
Incyte (INCY) United States $13.707B 104.13
Genmab (GMAB) Denmark $13.293B 14.91
Exelixis (EXEL) United States $11.751B 19.95
QIAGEN (QGEN) Netherlands $10.679B 20.78
Moderna (MRNA) United States $10.651B 0.00
Ascendis Pharma (ASND) Denmark $10.573B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
BioMarin Pharmaceutical (BMRN) United States $10.375B 16.85
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $9.984B 0.00
Exact Sciences (EXAS) United States $9.773B 0.00
Bio-Techne Corp (TECH) United States $8.277B 30.88
Blueprint Medicines (BPMC) United States $8.276B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.036B 0.00
Roivant Sciences (ROIV) United Kingdom $7.886B 0.00
Revolution Medicines (RVMD) United States $6.981B 0.00
Repligen (RGEN) United States $6.979B 78.12
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.506B 6.39
Halozyme Therapeutics (HALO) United States $6.473B 12.39
Guardant Health (GH) United States $6.198B 0.00
Legend Biotech (LEGN) United States $6.152B 0.00
TG Therapeutics (TGTX) United States $6.025B 158.12
Nuvalent (NUVL) United States $5.682B 0.00
Telix Pharmaceuticals (TLX) Australia $5.547B 0.00
Axsome Therapeutics (AXSM) United States $5.050B 0.00
Anbio Biotechnology (NNNN) Germany $4.841B 0.00
Alkermes (ALKS) Ireland $4.754B 12.76
Akero Therapeutics (AKRO) United States $4.487B 0.00
ADMA Biologics Inc (ADMA) United States $4.393B 32.86
Vaxcyte (PCVX) United States $4.242B 0.00
Krystal Biotech (KRYS) United States $4.120B 31.75
Cytokinetics (CYTK) United States $4.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.033B 0.00
Zai Lab (ZLAB) China $3.993B 0.00
PTC Therapeutics (PTCT) United States $3.927B 6.83
Zealand Pharma (ZLDPF) Denmark $3.910B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.909B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.717B 32.66
Merus (MRUS) Netherlands $3.681B 0.00
Avidity Biosciences (RNA) United States $3.595B 0.00
Arcellx (ACLX) United States $3.569B 0.00
Ascentage Pharma Group - (AAPG) China $3.555B 0.00
SpringWorks Therapeutics (SWTX) United States $3.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.509B 0.00
Protagonist Therapeutics (PTGX) United States $3.422B 73.62
Scholar Rock Holding (SRRK) United States $3.369B 0.00
Viking Therapeutics (VKTX) United States $3.164B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.027B 0.00
Metsera (MTSR) United States $3.016B 0.00
Kymera Therapeutics (KYMR) United States $2.977B 0.00
Alvotech (ALVO) Luxembourg $2.840B 16.24
Immunovant (IMVT) United States $2.801B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.674B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.504B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.471B 0.00
ImmunityBio (IBRX) United States $2.463B 0.00
Apellis Pharmaceuticals (APLS) United States $2.313B 0.00
Ligand Pharmaceuticals (LGND) United States $2.232B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.219B 0.00
Twist Bioscience (TWST) United States $2.213B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.195B 0.00
Denali Therapeutics (DNLI) United States $2.105B 0.00
Vericel (VCEL) United States $2.097B 1388.67
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.079B 0.00
Bavarian Nordic (BVNRY) Denmark $2.063B 10.90
Apogee Therapeutics (APGE) United States $2.017B 0.00
CG Oncology (CGON) United States $1.987B 0.00
IDEAYA Biosciences (IDYA) United States $1.952B 0.00
Agios Pharmaceuticals (AGIO) United States $1.949B 0.00
Belite Bio (BLTE) United States $1.907B 0.00
NovoCure (NVCR) Jersey $1.906B 0.00
Disc Medicine (IRON) United States $1.875B 0.00
Certara (CERT) United States $1.853B 34.61
Adaptive Biotechnologies (ADPT) United States $1.847B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.830B 12.16
GRAIL (GRAL) United States $1.776B 0.00
Amicus Therapeutics (FOLD) United States $1.752B 189.67
Beam Therapeutics (BEAM) United States $1.724B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.717B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.694B 0.00
Sarepta Therapeutics (SRPT) United States $1.693B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.608B 0.00
Biohaven (BHVN) United States $1.505B 0.00
Vera Therapeutics (VERA) United States $1.485B 0.00
89BIO (ETNB) United States $1.453B 0.00
ANI Pharmaceuticals (ANIP) United States $1.426B 14.69
Celldex Therapeutics (CLDX) United States $1.405B 0.00
Janux Therapeutics (JANX) United States $1.392B 0.00
Edgewise Therapeutics (EWTX) United States $1.374B 0.00
Mesoblast (MESO) Australia $1.374B 0.00
Travere Therapeutics (TVTX) United States $1.344B 0.00
BGM Group (BGM) China $1.246B 0.00
CureVac (CVAC) Germany $1.211B 5.87
Structure Therapeutics (GPCR) United States $1.209B 0.00
Dynavax Technologies (DVAX) United States $1.194B 71.00
Viridian Therapeutics (VRDN) United States $1.187B 0.00
MannKind (MNKD) United States $1.146B 23.56
AbCellera Biologics (ABCL) Canada $1.116B 0.00
Pacira BioSciences (PCRX) United States $1.098B 10.44
Liquidia Technologies (LQDA) United States $1.097B 0.00
WAVE Life Sciences (WVE) Singapore $1.094B 0.00
Niagen Bioscience (NAGE) United States $1.089B 153.56
Novavax (NVAX) United States $1.053B 2.45
CorMedix Inc (CRMD) United States $1.015B 68.00
Intellia Therapeutics (NTLA) United States $0.995B 0.00
Geron (GERN) United States $0.974B 0.00
Spyre Therapeutics (SYRE) United States $0.966B 0.00
Pharvaris (PHVS) Netherlands $0.936B 0.00
NeoGenomics (NEO) United States $0.921B 0.00
Mineralys Therapeutics (MLYS) United States $0.912B 0.00
Nurix Therapeutics (NRIX) United States $0.903B 0.00
Arcus Biosciences (RCUS) United States $0.900B 0.00
Praxis Precision Medicines (PRAX) United States $0.897B 0.00
Oric Pharmaceuticals (ORIC) United States $0.895B 0.00
MiMedx (MDXG) United States $0.877B 21.21
Zymeworks (ZYME) United States $0.861B 0.00
Oculis Holding AG (OCS) Switzerland $0.851B 0.00
LENZ Therapeutics (LENZ) United States $0.847B 0.00
Cogent Biosciences (COGT) United States $0.835B 0.00
Anavex Life Sciences (AVXL) United States $0.817B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.800B 0.00
ArriVent BioPharma (AVBP) United States $0.780B 0.00
UniQure (QURE) Netherlands $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.765B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Pharming Group (PHAR) Netherlands $0.736B 0.00
Vir Biotechnology (VIR) United States $0.734B 0.00
Replimune (REPL) United States $0.729B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.714B 0.00
Gyre Therapeutics (GYRE) United States $0.692B 184.50
AnaptysBio (ANAB) United States $0.687B 0.00
Immatics (IMTX) Germany $0.679B 0.00
Nuvation Bio (NUVB) United States $0.670B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.667B 0.00
Trevi Therapeutics (TRVI) United States $0.664B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.657B 0.00
Sionna Therapeutics (SION) United States $0.654B 0.00
Sana Biotechnology (SANA) United States $0.647B 0.00
Stoke Therapeutics (STOK) United States $0.646B 14.99
GH Research (GHRS) Ireland $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.615B 0.00
Arbutus Biopharma (ABUS) United States $0.613B 0.00
Urogen Pharma (URGN) United States $0.604B 0.00
Cidara Therapeutics (CDTX) United States $0.603B 0.00
Upstream Bio (UPB) United States $0.589B 0.00
Dianthus Therapeutics (DNTH) United States $0.583B 0.00
Sage Therapeutics (SAGE) United States $0.581B 0.00
Iovance Biotherapeutics (IOVA) United States $0.581B 0.00
Castle Biosciences (CSTL) United States $0.570B 38.72
Arvinas (ARVN) United States $0.569B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.562B 0.00
Maze Therapeutics (MAZE) United States $0.558B 0.00
Keros Therapeutics (KROS) United States $0.549B 0.00
MeiraGTx Holdings (MGTX) United States $0.536B 0.00
Tango Therapeutics (TNGX) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Tyra Biosciences (TYRA) United States $0.522B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.509B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.504B 0.00
Kura Oncology (KURA) United States $0.496B 0.00
Myriad Genetics (MYGN) United States $0.491B 0.00
Septerna (SEPN) United States $0.484B 0.00
Bicara Therapeutics (BCAX) United States $0.480B 0.00
ATyr Pharma (ATYR) United States $0.473B 0.00
Fortrea Holdings (FTRE) United States $0.471B 13.00
Cullinan Therapeutics (CGEM) United States $0.457B 0.00
Abivax SA (ABVX) France $0.456B 0.00
Celcuity (CELC) United States $0.455B 0.00
Kamada (KMDA) Israel $0.454B 27.24
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Cytek Biosciences (CTKB) United States $0.450B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.445B 0.00
REGENXBIO (RGNX) United States $0.439B 0.00
Rapport Therapeutics (RAPP) United States $0.431B 0.00
PureTech Health (PRTC) United States $0.431B 0.00
Zenas BioPharma (ZBIO) United States $0.425B 0.00
Precigen (PGEN) United States $0.422B 0.00
Fulcrum Therapeutics (FULC) United States $0.398B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.391B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
MBX Biosciences (MBX) United States $0.377B 0.00
Tectonic Therapeutic (TECX) United States $0.375B 0.00
Eton Pharmaceuticals (ETON) United States $0.374B 0.00
Solid Biosciences (SLDB) United States $0.373B 0.00
Vigil Neuroscience (VIGL) United States $0.371B 0.00
Emergent Biosolutions (EBS) United States $0.371B 0.00
Rezolute (RZLT) United States $0.369B 0.00
Northwest Biotherapeutics (NWBO) United States $0.364B 0.00
Compass Therapeutics (CMPX) United States $0.360B 0.00
Erasca (ERAS) United States $0.357B 0.00
Terns Pharmaceuticals (TERN) United States $0.349B 0.00
Prime Medicine (PRME) United States $0.348B 0.00
Absci (ABSI) United States $0.346B 0.00
Humacyte (HUMA) United States $0.344B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.336B 0.00
Prothena (PRTA) Ireland $0.333B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.333B 0.00
Amarin (AMRN) Ireland $0.329B 0.00
XOMA Royalty (XOMA) United States $0.327B 0.00
Benitec Biopharma (BNTC) United States $0.324B 0.00
Aura Biosciences (AURA) United States $0.316B 0.00
Olema Pharmaceuticals (OLMA) United States $0.312B 0.00
Astria Therapeutics (ATXS) United States $0.307B 0.00
Lifecore Biomedical (LFCR) United States $0.305B 0.00
Inventiva S.A (IVA) France $0.303B 0.00
Atea Pharmaceuticals (AVIR) United States $0.302B 0.00
Abeona Therapeutics (ABEO) United States $0.302B 0.00
Ocugen (OCGN) United States $0.301B 0.00
Aardvark Therapeutics (AARD) United States $0.301B 0.00
Cartesian Therapeutics (RNAC) United States $0.297B 0.00
Gossamer Bio (GOSS) United States $0.295B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.287B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.287B 58.25
Vanda Pharmaceuticals (VNDA) United States $0.284B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.277B 0.00
Alpha Teknova (TKNO) United States $0.273B 0.00
Foghorn Therapeutics (FHTX) United States $0.271B 0.00
Annexon (ANNX) United States $0.269B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.268B 0.00
Sagimet Biosciences (SGMT) United States $0.267B 0.00
Entrada Therapeutics (TRDA) United States $0.266B 8.67
Allogene Therapeutics (ALLO) United States $0.262B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.252B 0.00
Candel Therapeutics (CADL) United States $0.252B 0.00
Citius Oncology (CTOR) United States $0.250B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
MaxCyte (MXCT) United States $0.245B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
Neurogene (NGNE) United States $0.236B 0.00
Tvardi Therapeutics (TVRD) United States $0.236B 0.00
Verastem (VSTM) United States $0.229B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
Palvella Therapeutics (PVLA) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.227B 0.00
BioStem Technologies (BSEM) $0.223B 9.10
Y-mAbs Therapeutics (YMAB) United States $0.217B 0.00
Semper Paratus Acquisition (TVGN) United States $0.217B 0.00
Design Therapeutics (DSGN) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.214B 0.13
Monopar Therapeutics (MNPR) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.210B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
AC Immune (ACIU) Switzerland $0.210B 0.00
Codexis (CDXS) United States $0.209B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.208B 0.00
SELLAS Life Sciences (SLS) United States $0.203B 0.00
Kodiak Sciences (KOD) United States $0.199B 0.00
CARGO Therapeutics (CRGX) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
CytomX Therapeutics (CTMX) United States $0.186B 4.81
EnGene Holdings (ENGN) Canada $0.183B 0.00
Alumis (ALMS) United States $0.180B 0.00
Editas Medicine (EDIT) United States $0.177B 0.00
Innate Pharma S.A (IPHA) France $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Ventyx Biosciences (VTYX) United States $0.174B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.166B 0.00
I-Mab (IMAB) United States $0.165B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.165B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Puma Biotechnology (PBYI) United States $0.164B 4.30
DiaMedica Therapeutics (DMAC) United States $0.163B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
Nuvectis Pharma (NVCT) United States $0.161B 0.00
Rapt Therapeutics (RAPT) United States $0.161B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Anika Therapeutics (ANIK) United States $0.155B 0.00
Alector (ALEC) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.150B 0.00
Alpha Cognition (ACOG) Canada $0.148B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Instil Bio (TIL) United States $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
INmune Bio (INMB) United States $0.144B 0.00
Black Diamond Therapeutics (BDTX) United States $0.140B 41.00
Agenus (AGEN) United States $0.135B 0.00
Skye Bioscience (SKYE) United States $0.132B 0.00
Sangamo Therapeutics (SGMO) United States $0.130B 0.00
Neumora Therapeutics (NMRA) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.126B 0.00
Fate Therapeutics (FATE) United States $0.126B 0.00
Caribou Biosciences (CRBU) United States $0.126B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.123B 0.00
Nkarta (NKTX) United States $0.123B 0.00
Seer (SEER) United States $0.121B 0.00
Greenwich LifeSciences (GLSI) United States $0.119B 0.00
23andMe Holding (MEHCQ) United States $0.118B 0.00
Genelux (GNLX) United States $0.115B 0.00
Immuneering (IMRX) United States $0.115B 0.00
Actuate Therapeutics (ACTU) United States $0.114B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.114B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
BioHarvest Sciences (BHST) Canada $0.112B 0.00
Vor Biopharma (VOR) $0.111B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.110B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.109B 0.00
C4 Therapeutics (CCCC) United States $0.108B 0.00
Theratechnologies (THTX) Canada $0.108B 0.00
Contineum Therapeutics (CTNM) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.102B 0.00
BeyondSpring (BYSI) United States $0.102B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
HilleVax (HLVX) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Invivyd (IVVD) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Whitehawk Therapeutics (WHWK) United States $0.090B 0.00
XBiotech (XBIT) United States $0.088B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Jasper Therapeutics (JSPR) United States $0.085B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
Coherus Oncology (CHRS) United States $0.085B 0.00
TScan Therapeutics (TCRX) United States $0.084B 0.00
Seres Therapeutics (MCRB) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.083B 0.00
Inovio Pharmaceuticals (INO) United States $0.083B 0.00
OKYO Pharma (OKYO) $0.082B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Pliant Therapeutics (PLRX) United States $0.080B 0.00
Zura Bio (ZURA) United States $0.079B 0.00
Elutia (ELUT) United States $0.076B 0.00
Forte Biosciences (FBRX) United States $0.075B 0.00
Biomea Fusion (BMEA) United States $0.075B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
TELA Bio (TELA) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.068B 0.00
Immunic (IMUX) United States $0.068B 0.00
Oncolytics Biotech (ONCY) Canada $0.068B 0.00
Sutro Biopharma (STRO) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
PDS Biotechnology (PDSB) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Alto Neuroscience (ANRO) United States $0.062B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Quantum Biopharma (QNTM) Canada $0.061B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
Renovaro (RENB) United States $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.058B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Senti Biosciences (SNTI) United States $0.055B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Applied Therapeutics (APLT) United States $0.054B 0.00
Adverum Biotechnologies (ADVM) United States $0.052B 0.00
Werewolf Therapeutics (HOWL) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Precision BioSciences (DTIL) United States $0.046B 0.00
Celularity (CELU) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Annovis Bio (ANVS) United States $0.042B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Artiva Biotherapeutics (ARTV) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
ABVC BioPharma (ABVC) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Scilex Holding (SCLX) United States $0.037B 0.00
Clene (CLNN) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Exicure (XCUR) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
KALA BIO (KALA) United States $0.034B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.028B 0.00
FibroBiologics (FBLG) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Generation Bio (GBIO) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Eyenovia (EYEN) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Cadrenal Therapeutics (CVKD) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
CalciMedica (CALC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
Gelteq (GELS) Australia $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Rallybio (RLYB) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Advanced Biomed (ADVB) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Equillium (EQ) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
X4 Pharmaceuticals (XFOR) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00